Most cited papers in Diverse Scientific Research Studies
What are the most cited papers in Diverse Scientific Research Studies?
The most cited paper in Diverse Scientific Research Studies is "Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats" (Saritha Marella, Dilip Rajasekhar Maddirela, Kameswara Rao Badri et al., 2015), with 5,950 citations. Next come "Psychosocial impact of COVID-19" (2,016) and "Sampling Methods in Research Methodology; How to Choose a Sampling Technique for Research" (1,976).
Showing 50 of 100 papers. Every paper with more than 245 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats Saritha Marella, Dilip Rajasekhar Maddirela, Kameswara Rao Badri et al. · Cellular Physiology and Biochemistry | 2015 | 5,950 |
| 2 | Psychosocial impact of COVID-19 Souvik Dubey, Payel Biswas, Ritwik Ghosh et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews | 27 May 2020 | 2,016 |
| 3 | Sampling Methods in Research Methodology; How to Choose a Sampling Technique for Research Hamed Taherdoost · SSRN Electronic Journal | 2016 | 1,976 |
| 4 | Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations Shweta Singh, Deblina Roy, Krittika Sinha et al. · Psychiatry Research | 24 Aug 2020 | 1,789 |
| 5 | Mental health problems faced by healthcare workers due to the COVID-19 pandemic–A review Mamidipalli Sai Spoorthy, Sree Karthik Pratapa, Supriya Mahant · Asian Journal of Psychiatry | 22 Apr 2020 | 1,425 |
| 6 | Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies. Pio Conti · Journal of Biological Regulators and Homeostatic Agents/Journal of Biological Regulators & Homeostatic Agents | Mar 2020 | 1,268 |
| 7 | COVID-19, SARS and MERS: are they closely related? Nicola Petrosillo, Giulio Viceconte, Önder Ergönül et al. · Clinical Microbiology and Infection | 28 Mar 2020 | 1,147 |
| 8 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response Indwiani Astuti, Ysrafil Ysrafil · Diabetes & Metabolic Syndrome Clinical Research & Reviews | 17 Apr 2020 | 1,145 |
| 9 | The Inconvenient Truth About Convenience and Purposive Samples Chittaranjan Andrade · Indian Journal of Psychological Medicine | 17 Dec 2020 | 1,085 |
| 10 | Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Mayla Gabriela Silva Borba et al. · JAMA Network Open | 24 Apr 2020 | 981 |
| 11 | Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study Abdo A. Elfiky · Life Sciences | 25 Mar 2020 | 968 |
| 12 | Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults Romina Libster et al. · New England Journal of Medicine | 6 Jan 2021 | 947 |
| 13 | Designing of interferon-gamma inducing MHC class-II binders Sandeep Kumar Dhanda, Pooja Vir, Gajendra P. S. Raghava · Biology Direct | Dec 2013 | 877 |
| 14 | Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar Hiam Chemaitelly et al. · New England Journal of Medicine | 6 Oct 2021 | 874 |
| 15 | Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. Amir Emami, Fatemeh Javanmardi, Neda Pirbonyeh et al. · PubMed | 2020 | 814 |
| 16 | Anti-HCV, nucleotide inhibitors, repurposing against COVID-19 Abdo A. Elfiky · Life Sciences | 28 Feb 2020 | 747 |
| 17 | Get vaccinated when it is your turn and follow the local guidelines I Wayan Suryasa, María Rodríguez Gámez, Tihnov Koldoris · International Journal of Health Sciences | 29 Dec 2021 | 734 |
| 18 | The role of biomarkers in diagnosis of COVID-19 – A systematic review Muhammed Kermali, Raveena Kaur Khalsa, Kiran Pillai et al. · Life Sciences | 13 May 2020 | 724 |
| 19 | [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Jun Chen, Danping Liu, Li Liu et al. · PubMed | 25 May 2020 | 705 |
| 20 | Flavonoids as natural phenolic compounds and their role in therapeutics: an overview Rakesh Eshwarlal Mutha, Anilkumar Uttamchand Tatiya, Sanjay Javerilal Surana · Future Journal of Pharmaceutical Sciences | 20 Jan 2021 | 628 |
| 21 | Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection Yaseen M. Arabi, Ahmed A. Arifi, Hanan H. Balkhy et al. · Annals of Internal Medicine | 28 Jan 2014 | 593 |
| 22 | The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19 Francis K. Yoshimoto · The Protein Journal | 23 May 2020 | 587 |
| 23 | Menstrual hygiene: How hygienic is the adolescent girl? Aparajita Dasgupta, Madhutandra Sarkar · Indian Journal of Community Medicine | 2008 | 586 |
| 24 | 2019 Novel Coronavirus (COVID-19) Outbreak: A Review of the Current Literature Ahmet Rıza Şahin, Aysegul Erdogan, Pelin Mutlu Agaoglu et al. · Eurasian Journal of Medicine and Oncology | 12 Feb 2020 | 545 |
| 25 | A Review of Leishmaniasis: Current Knowledge and Future Directions Sarah Mann, Katherine Frasca, Sara Scherrer et al. · Current Tropical Medicine Reports | 17 Mar 2021 | 541 |
| 26 | Revisiting the Green Synthesis of Nanoparticles: Uncovering Influences of Plant Extracts as Reducing Agents for Enhanced Synthesis Efficiency and Its Biomedical Applications Harjeet Singh, Martín F. Desimone, Shivani R. Pandya et al. · International Journal of Nanomedicine | Aug 2023 | 538 |
| 27 | Totally Drug-Resistant Tuberculosis in India Zarir Farokh Udwadia, Rohit Amale, K. Ajbani et al. · Clinical Infectious Diseases | 21 Dec 2011 | 531 |
| 28 | DRUG SENSITIVITY OF PLASMODIUM FALCIPARUM Karl H. Rieckmann, Gary H. Campbell, L. J. Sax et al. · The Lancet | 1978 | 517 |
| 29 | Coronavirus Disease 2019 (COVID-19) Awni farhan Ismael Alani · Acta Scientific Dental Scienecs | 2022 | 514 |
| 30 | Adams Becker, S.; Cummins, M.; Davis, A.; Freeman, A.; Hall Giesinger, C.; Ananthanarayanan, V. NMC Horizon Report: 2017 Higher Education Edition. Austin, Texas: The New Media Consortium, 2017 Sebastián Gómez Jaramillo · Cuaderno activa | 2017 | 514 |
| 31 | Standard Short-Course Chemotherapy for Drug-Resistant Tuberculosis Marcos Espinal, Sang‐Jae Kim, Pedro Guillermo Suarez et al. · JAMA | 17 May 2000 | 512 |
| 32 | Ethnobotanical survey of medicinal plants used by people in Oriental Morocco to manage various ailments Jamila Fakchich, Mostafa Elachouri · Journal of Ethnopharmacology | 28 Mar 2014 | 488 |
| 33 | Methodology Update Sara McPherson, Cynthia Reese, Mary Cecilia Wendler · Nursing Research | 26 Jul 2018 | 480 |
| 34 | Synthesis of silver nanoparticles using leaves of Catharanthus roseus Linn. G. Don and their antiplasmodial activities S Ponarulselvam, Chellasamy Panneerselvam, Kadarkarai Murugan et al. · Asian Pacific Journal of Tropical Biomedicine | 30 Apr 2012 | 478 |
| 35 | Gold Nanoparticles: A Revival in Precious Metal Administration to Patients Avnesh S. Thakor, Jesse V. Jokerst, Cristina L. Zavaleta et al. · Nano Letters | 16 Aug 2011 | 470 |
| 36 | The impact of COVID-19 pandemic on mental health & wellbeing among home-quarantined Bangladeshi students: A cross-sectional pilot study Abid Hasan Khan, Sadia Sultana, Sahadat Hossain et al. · Journal of Affective Disorders | 6 Aug 2020 | 461 |
| 37 | Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study Siti Khaerunnisa, Hendra Kurniawan, Rizki Awaluddin et al. · Preprints.org | 13 Mar 2020 | 455 |
| 38 | Aedes (Stegomyia) albopictus (Skuse): A Potential Vector of Zika Virus in Singapore Pei Sze Jeslyn Wong, Mei Zhi Irene Li, Chee‐Seng Chong et al. · PLoS neglected tropical diseases | Aug 2013 | 449 |
| 39 | Effectiveness of Digital Marketing in the Challenging Age: An Empirical Study Afrina Yasmin, Sadia Tasneem, Kaniz Fatema · THE INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE AND BUSINESS ADMINISTRATION | 2015 | 443 |
| 40 | Antiviral activity of four types of bioflavonoid against dengue virus type-2 Keivan Zandi, Boon‐Teong Teoh, Sing‐Sin Sam et al. · Virology Journal | Dec 2011 | 431 |
| 41 | In silico studies on therapeutic agents for COVID-19: Drug repurposing approach Bhumi M. Shah, Palmi Modi, Sneha R. Sagar · Life Sciences | 9 Apr 2020 | 424 |
| 42 | Psychological impact of COVID-19 lockdown: An online survey from India Sandeep Grover et al. · Indian Journal of Psychiatry | 2020 | 422 |
| 43 | Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study Rob W. van der Pluijm et al. · The Lancet Infectious Diseases | 22 Jul 2019 | 421 |
| 44 | Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis Carole Diane Mitnick et al. · New England Journal of Medicine | 6 Aug 2008 | 403 |
| 45 | A systemic review on tuberculosis Arvind Natarajan, Parvangada Madappa Beena, Anushka V. Devnikar et al. · Indian Journal of Tuberculosis | 28 Feb 2020 | 401 |
| 46 | Types of sampling in research Pooja Bhardwaj · Journal of the Practice of Cardiovascular Sciences | 2019 | 400 |
| 47 | Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Abigail Wright, Matteo Zignol, Armand Van Deun et al. · The Lancet | 17 Apr 2009 | 391 |
| 48 | 2019 Novel Coronavirus—Important Information for Clinicians Carlos del Rı́o, Preeti Malani · JAMA | 5 Feb 2020 | 388 |
| 49 | The Effect of Type 2 Diabetes Mellitus on the Presentation and Treatment Response of Pulmonary Tuberculosis Bachti Alisjahbana, Edhyana Sahiratmadja, Erni Juwita Nelwan et al. · Clinical Infectious Diseases | 25 Jul 2007 | 384 |
| 50 | Nutraceutical or Pharmacological Potential of Moringa oleifera Lam. Xianjuan Kou, Biao Li, Julia B. Olayanju et al. · Nutrients | 12 Mar 2018 | 376 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.